KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsBuildingsCash & Current InvestmentsCash & EquivalentsCommon EquityConstruction in ProgressCurrent AssetsCurrent TaxesDividends payablesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtOther Accumulated ExpensesPayablesPensionPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Abbott Laboratories (ABT) Short term Debt (2016 - 2025)

Abbott Laboratories' Short term Debt history spans 17 years, with the latest figure at $3.0 billion for Q4 2025.

  • For Q4 2025, Short term Debt rose 102.2% year-over-year to $3.0 billion; the TTM value through Dec 2025 reached $3.0 billion, up 102.2%, while the annual FY2025 figure was $3.0 billion, 102.2% up from the prior year.
  • Short term Debt for Q4 2025 was $3.0 billion at Abbott Laboratories, up from $1.3 billion in the prior quarter.
  • Across five years, Short term Debt topped out at $3.0 billion in Q4 2025 and bottomed at $4.0 million in Q1 2022.
  • The 5-year median for Short term Debt is $1.1 billion (2022), against an average of $1.2 billion.
  • The largest annual shift saw Short term Debt crashed 99.34% in 2022 before it surged 57025.0% in 2023.
  • A 5-year view of Short term Debt shows it stood at $754.0 million in 2021, then soared by 198.54% to $2.3 billion in 2022, then crashed by 52.02% to $1.1 billion in 2023, then skyrocketed by 38.89% to $1.5 billion in 2024, then soared by 102.2% to $3.0 billion in 2025.
  • Per Business Quant, the three most recent readings for ABT's Short term Debt are $3.0 billion (Q4 2025), $1.3 billion (Q3 2025), and $507.0 million (Q2 2025).